Yun Bai

1.3k total citations
29 papers, 924 citations indexed

About

Yun Bai is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Yun Bai has authored 29 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Yun Bai's work include Lung Cancer Treatments and Mutations (10 papers), Advanced Radiotherapy Techniques (5 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Yun Bai is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Advanced Radiotherapy Techniques (5 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Yun Bai collaborates with scholars based in United States, China and Japan. Yun Bai's co-authors include Eric B. Haura, John M. Koomen, Bin Fang, Steven A. Eschrich, Jiannong Li, Fumi Kinose, Uwe Rix, Alison J. Edwards, Lanxi Song and Guolin Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Yun Bai

27 papers receiving 917 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yun Bai United States 15 612 318 291 144 102 29 924
Joan MacNeill United States 6 841 1.4× 303 1.0× 170 0.6× 135 0.9× 153 1.5× 6 1.1k
Rana Anjum United States 10 864 1.4× 259 0.8× 239 0.8× 85 0.6× 48 0.5× 20 1.2k
Fumi Kinose United States 17 595 1.0× 265 0.8× 157 0.5× 146 1.0× 54 0.5× 26 857
Jon Burrows United States 9 674 1.1× 429 1.3× 238 0.8× 134 0.9× 109 1.1× 20 1.1k
Weiguo Wu United States 16 601 1.0× 314 1.0× 99 0.3× 152 1.1× 63 0.6× 33 978
Gabriel Ricolleau France 14 626 1.0× 402 1.3× 200 0.7× 344 2.4× 62 0.6× 18 1.1k
Charles Pottier Belgium 14 539 0.9× 362 1.1× 218 0.7× 299 2.1× 171 1.7× 15 1.0k
Lars Blumenstein Germany 18 944 1.5× 347 1.1× 298 1.0× 143 1.0× 36 0.4× 37 1.3k
Emmy D.G. Fleuren Netherlands 17 497 0.8× 368 1.2× 307 1.1× 108 0.8× 26 0.3× 25 871
Ping‐Chieh Chou United States 17 708 1.2× 371 1.2× 133 0.5× 262 1.8× 63 0.6× 23 1.1k

Countries citing papers authored by Yun Bai

Since Specialization
Citations

This map shows the geographic impact of Yun Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun Bai more than expected).

Fields of papers citing papers by Yun Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yun Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun Bai. The network helps show where Yun Bai may publish in the future.

Co-authorship network of co-authors of Yun Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Yun Bai. A scholar is included among the top collaborators of Yun Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yun Bai. Yun Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bai, Yun, Xianshu Gao, Shanshi Li, et al.. (2024). Partial Stereotactic Ablative Radiotherapy Boost Before Conventional Radiotherapy (P‐SABR) for Large (> 5 cm) Unresectable Stage III Nonsmall Cell Lung Cancer. Thoracic Cancer. 16(2). e15514–e15514. 1 indexed citations
2.
Huang, Lei, Xianshu Gao, Yue Li, et al.. (2024). Enhancing stereotactic ablative boost radiotherapy dose prediction for bulky lung cancer: A multi‐scale dilated network approach with scale‐balanced structure loss. Journal of Applied Clinical Medical Physics. 26(1). e14546–e14546. 1 indexed citations
3.
Chen, Jie, et al.. (2023). Partial Stereotactic Ablative Radiotherapy in Bulky Urinary Tract Malignancy: An Update Clinical Outcomes and Dosimetric Analysis. International Journal of Radiation Oncology*Biology*Physics. 117(2). e371–e371.
4.
Qi, Xin, Xianshu Gao, Yun Bai, et al.. (2023). Treatment-related neuroendocrine prostate cancer managed with partial stereotactic ablative radiotherapy (P-SABR) for long-term survival: a case series. Translational Andrology and Urology. 12(1). 128–138. 3 indexed citations
5.
Li, Hongzhen, Xianshu Gao, Xiaomei Li, et al.. (2023). Dose-Intensified Postoperative Radiation Therapy for Prostate Cancer: Long-Term Results From the PKUFH Randomized Phase 3 Trial. International Journal of Radiation Oncology*Biology*Physics. 118(3). 697–705.
6.
Komarow, Hirsh D., Andrea Naranjo, Margery Smelkinson, et al.. (2020). Mechanical Activation of ADGRE2 Causes Calcium-dependent Activation of PI3K and MAPK Pathways Driving Mast Cell Degranulation and PGD2 Production. Journal of Allergy and Clinical Immunology. 145(2). AB186–AB186. 1 indexed citations
7.
Hong, Xin, Xianshu Gao, Xiaobin Gu, et al.. (2018). Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of <em>AKR1C3</em>. Cancer Management and Research. Volume 10. 3149–3158. 13 indexed citations
8.
Gu, Xiaobin, Xianshu Gao, Ming Cui, et al.. (2018). Survival outcomes of radical prostatectomy and external beam radiotherapy in clinically localized high-risk prostate cancer: a population-based, propensity score matched study. Cancer Management and Research. Volume 10. 1061–1067. 18 indexed citations
9.
Wang, Xia, et al.. (2017). Ultrasonographic Features of Female Urethral Diverticula: A Retrospective Study of 25 Patients. Female Pelvic Medicine & Reconstructive Surgery. 23(5). 343–347. 4 indexed citations
10.
Cui, Ming, Xianshu Gao, Xiaobin Gu, et al.. (2017). BRCA2 mutations should be screened early and routinely as markers of poor prognosis: evidence from 8,988 patients with prostate cancer. Oncotarget. 8(25). 40222–40232. 17 indexed citations
11.
Kim, Jae‐Young, Eric A. Welsh, Bin Fang, et al.. (2016). Phosphoproteomics Reveals MAPK Inhibitors Enhance MET- and EGFR-Driven AKT Signaling in KRAS -Mutant Lung Cancer. Molecular Cancer Research. 14(10). 1019–1029. 54 indexed citations
12.
Li, Jiannong, Bin Fang, Fumi Kinose, et al.. (2016). Target Identification in Small Cell Lung Cancer via Integrated Phenotypic Screening and Activity-Based Protein Profiling. Molecular Cancer Therapeutics. 15(2). 334–342. 18 indexed citations
13.
Haake, Scott M., Jiannong Li, Yun Bai, et al.. (2016). Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry–Based Phosphotyrosine Proteomics. Clinical Cancer Research. 22(22). 5605–5616. 19 indexed citations
14.
Bai, Yun, Jae‐Young Kim, Bin Fang, et al.. (2014). Adaptive Responses to Dasatinib-Treated Lung Squamous Cell Cancer Cells Harboring DDR2 Mutations. Cancer Research. 74(24). 7217–7228. 34 indexed citations
15.
Yoshida, Takeshi, Guolin Zhang, Matthew A. Smith, et al.. (2014). Tyrosine Phosphoproteomics Identifies Both Codrivers and Cotargeting Strategies for T790M-Related EGFR-TKI Resistance in Non–Small Cell Lung Cancer. Clinical Cancer Research. 20(15). 4059–4074. 89 indexed citations
16.
Bai, Yun, Jiannong Li, Bin Fang, et al.. (2012). Phosphoproteomics Identifies Driver Tyrosine Kinases in Sarcoma Cell Lines and Tumors. Cancer Research. 72(10). 2501–2511. 98 indexed citations
17.
Chen, Yang, Liming Yang, Yun Bai, et al.. (2012). The trends in mortalities of malignant tumors in Pudong New Area in Shanghai from 1993 to 2007. Tumori. 32(5). 372–375. 3 indexed citations
18.
Li, Jiannong, Uwe Rix, Bin Fang, et al.. (2010). A chemical and phosphoproteomic characterization of dasatinib action in lung cancer. Nature Chemical Biology. 6(4). 291–299. 219 indexed citations
19.
Machida, Kazuya, Steven A. Eschrich, Jiannong Li, et al.. (2010). Characterizing Tyrosine Phosphorylation Signaling in Lung Cancer Using SH2 Profiling. PLoS ONE. 5(10). e13470–e13470. 31 indexed citations
20.
Zhang, Guolin, Bin Fang, Hui‐Yi Lin, et al.. (2010). Mass Spectrometry Mapping of Epidermal Growth Factor Receptor Phosphorylation Related to Oncogenic Mutations and Tyrosine Kinase Inhibitor Sensitivity. Journal of Proteome Research. 10(1). 305–319. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026